Pharmaceutical Antitrust Legislation To Watch

Law360 (May 28, 2019, 2:52 PM EDT) -- When voters were recently surveyed about their health care goals, 93% of respondents unsurprisingly identified “lowering prescription drug costs for as many Americans as possible” as an important priority.[1] This is not a new concern for most Americans, and government officials have long promised to address drug pricing. However, with increased public pressure, legislators and executive officials have proposed a flurry of bills and administrative actions aimed at lowering drug pricing.

Drug pricing is a challenging subject due to a complex distribution chain, a need to balance safety and innovation with cost, and the involvement of third-party service vendors such as pharmacy...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS